Entero Healthcare Solutions
ENTERO · NSE · Healthcare · India
Financials at a glance
Source: Yahoo FinanceAnnual
Quarterly · last 5
Revenue (FY2026)
₹6,591 Cr
Net margin
1.7%
Revenue CAGR (2y)
+29.6%
Net profit (FY2026)
₹115 Cr
Ask MarketChacha about ENTERO
Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.
Why it moved
- Jul 27, 2026
No specific company catalyst or news was reported today; the stock rose in line with broader market or sector movement.
· confidence: low
Daily moves with the verified reason behind them. Education only — not investment advice.
Financials
Yearly
| Period | Revenue | Net profit | Net margin |
|---|---|---|---|
| FY2026 | ₹6,591 Cr | ₹115 Cr | 1.7% |
| FY2025 | ₹5,096 Cr | ₹95 Cr | 1.9% |
| FY2024 | ₹3,922 Cr | ₹39 Cr | 1.0% |
| FY2023 | — | ₹-12 Cr | — |
Quarterly
| Period | Revenue | Net profit | EPS | Net margin |
|---|---|---|---|---|
| Q1 FY27 | ₹1,940 Cr | ₹52 Cr | 8.77 | 2.7% |
| Q4 FY26 | ₹1,910 Cr | ₹28 Cr | — | 1.5% |
| Q3 FY26 | ₹1,707 Cr | ₹28 Cr | — | 1.6% |
| Q2 FY26 | ₹1,571 Cr | ₹32 Cr | — | 2.0% |
| Q1 FY26 | ₹1,404 Cr | ₹28 Cr | — | 2.0% |
Figures as reported, in ₹ (crore). Source: Yahoo Finance.
Filings & announcements
2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Surbhi Singh - Prasid Uno Family Trust
BSE9/22/2026Entero Healthcare Solutions Limited Has Informed The Exchange About General Updates
Entero Healthcare Solutions Limited has informed the Exchange about General Updates
BSE9/12/2026Completion of tenure of Mr. Rajesh Shashikant Dalal
BSE8/24/2026Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Voting Results along with copy of Scrutinizer''s Report
BSE8/19/2026materialShareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of Annual General Meeting held on Wednesday, August 19, 2026.
BSE8/19/2026materialTranscript of Earnings Call / Conference Call
BSE8/17/2026Unaudited Financial Results For The Quarter Ended June 30, 2026.
Unaudited Financial Results for the Quarter ended June 30, 2026.
BSE8/7/2026Board Meeting Outcome for Outcome Of Board Meeting Held On August 07, 2026
Outcome of Board Meeting held on August 07, 2026
BSE8/7/2026Updated Annual Report Of The Company For The Financial Year 2025-26
Updated Annual Report of the Company for the financial year 2025-26
BSE7/30/2026Annual Report for the financial year 2025-26 along with the Notice convening the 8th Annual General Meeting
BSE7/27/2026Intimation regarding dispatch of letters to those Shareholders whose email addresses are not registered with Company/ Registrar and Share Transfer Agent/Depository Participant(s).
BSE7/27/2026Business Responsibility and Sustainability Reporting (BRSR)
Business Responsibility and Sustainability Report for the Financial Year 2025-26
BSE7/27/2026Annual Report for the financial year 2025-26
BSE7/27/2026Notice Convening The 8Th Annual General Meeting
The 8th Annual General Meeting of the Members of Entero Healthcare Solutions Limited is scheduled to be held on Wednesday, August 19, 2026, at 12:30 p.m. (IST) through Video Conferencing/Other ....
BSE7/27/2026material
In the news
- Entero Healthcare Solutions Share Price Falls 5.58% TodayUnivest · 10/19/2026
- Entero Healthcare Solutions (ENTERO) Share Price, NSETechGraph · 10/8/2026
- Entero Healthcare Solutions (ENTERO.NS) Slips 2.90% to ₹1713.8 as Stock Tests Mid-Range Levels - Inverse ETF Flowsiam.in · 9/30/2026
- Entero Healthcare gains 4% after completing majority acquisition of Anand ChemiceuticsAlice Blue · 9/29/2026
- Compare withEquitymaster · 9/28/2026
- Entero Healthcare Solutions: Best Stock in Sector? Key Metricsunivest.in · 9/25/2026
- Entero Healthcare Solutions to host virtual analyst call on September 29scanx.trade · 9/22/2026
- Prasad Uno Family Trust sells 2.13m Entero Healthcare sharesscanx.trade · 9/22/2026
Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.